在短视频观看期间抑制大脑活动:神经化学见解
Tiantian Hong1, Conghui Su2, Hui Zhou3
1Department of Psychology and Behavioral Sciences, Zhejiang University, Hangzhou 310058, China.
NeuroImage
|January 16, 2026
概括
观看短视频会禁用对认知控制至关重要的大脑区域,比如背前带带皮层 (dACC) 和背侧前额皮层 (dlPFC). 这种抑制的个体差异与dACC中的谷氨酸水平有关.
科学领域:
- 神经科学是一个神经科学.
- 认知科学 认知科学
- 神经成像是一种神经成像.
背景情况:
- 认知控制,涉及背前环状皮层 (dACC) 和背侧前额皮层 (dlPFC),对于适应环境需求至关重要.
- 短视频的消费可以将神经处理转向情感参与,可能会减少自我控制,导致过度使用.
研究的目的:
- 调查短视频观看是否抑制认知控制区域 (dACC,dlPFC).
- 探索神经化学因素,特别是谷氨酸和GABA,这些抑制的基础是个体差异.
主要方法:
- 使用质子磁共振光谱 (1H-MRS) 来测量dACC中的静态谷氨酸和GABA.
- 在56名年轻成年人中使用功能磁共振成像 (fMRI) 来评估短视频观看期间的dACC和dlPFC活动.
主要成果:
- 在观看喜欢的视频时,与不太喜欢的视频相比,观察到dACC和dlPFC的显著停用.
- 在dACC中休息状态的谷氨酸水平与失活程度相关;更高的谷氨酸与更少的抑制有关.
- 在首选视频观看时,dACC和dlPFC之间的功能连接性增加.
结论:
- 沉浸式短视频观看会使大脑的认知控制网络失效.
- 这种神经抑制的个体变异与dACC中的谷氨酸酸代谢有关.
- 研究结果提供了关于短视频参与的神经机制的见解,以及其对自我调节和过度使用数字媒体的影响.
相关概念视频
Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...


